YTEN stock: buy or sell?

YTEN stock price: $6.77 8.32% At close on January 24th, 2020

Updated on:
January 24th, 2020

0

After sliding a hair-raising -9.76% on January 23rd, Yield10 Bioscience closed yesterday at $6.77 and boosted an outstanding 8.32%.

Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States.

Should I buy YTEN stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best moment to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

None of our preferred buy setups matches with Yield10 Bioscience stock situation right now, therefore this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Yield10 Bioscience stock a buy?

Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness. At Stocks2.com, we detected 5 ratings published for YTEN stock in the last 30 days.

The general sentiment of these ratings is bullish for YTEN stock, with 5 positive ratings.
Is YTEN a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-8-20National Securitiesn/aBuy
2019-8-13National SecuritiesBuyBuy
2019-8-13Aegisn/aBuy
2019-7-22Aegisn/aBuy
2019-3-26Maxim Groupn/aBuy

YTEN stock analysis

Daily outlook

After sliding a hair-raising -9.76% on January 23rd, Yield10 Bioscience closed yesterday at $6.77 and boosted an outstanding 8.32%.

After sliding a hair-raising -9.76% on Jan 23rd, Yield10 Bioscience closed yesterday at $6.77 and boosted an outstanding 8.32%.

YTEN stock chart (daily)

Weekly outlook

After sliding a frightening -29.41% in a week last week, Yield10 Bioscience closed this week at $6.77 and remained stable a lame -0.44%. Early January YTEN rocketed an outstanding 9.09% in just one week.

Since price and 40-weeks moving average lines crossed down early March, YTEN fell $-46.43 per share (-87.27%). Trading stocks that are below the 40-weeks (that is, 200-days) moving average line is not recommended by many experts, as it indicates that the stock has not enough institutional support.

YTEN stock chart (weekly)

YTEN stock price history

YTEN stock went public on November 10th, 2006 with a price of $34,200.001. Since then, YTEN stock sliced a -100.00%, with a yearly average of -7.70%.

1: Adjusted price after possible price splits or reverse-splits.

YTEN stock historical price chart

YTEN stock reached 52-week highs on March at $70.80, and all-time highs 2007-04-27 with a price of 70488.

YTEN stock price target is $4.00

Nobody can reliably foresee how stock prices may evolve in the future. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last 30 days we found 3 price predictions for YTEN stock:
YTEN stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-8-13National SecuritiesReiterates$5.00$5.000%
2019-8-13AegisReiteratesn/a$2.00-
2019-3-26Maxim GroupSet Price Targetn/a$5.00-
(in average)$5.00$4.00-20.0%
Moving in a range from $5.00 and $2.00, the price prediction for YTEN stock is $4.00. In average, analysts' outlook on YTEN price target is negative, downgrading the forecast by a -20.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

After presenting its last earnings report on March, Yield10 Bioscience . As soon as we get its actual EPS from the earnings report, we will update this report.
YTEN earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q1-n/a-0.74n/a
2017-Q2-n/a-0.96n/a
2017-Q3-n/a-0.59n/a
2017-Q42018-03-08n/a-0.99n/a
2018-Q12018-05-10n/a-0.24n/a
2018-Q22018-08-09n/a-0.24n/a
2018-Q32018-11-08n/a-0.26n/a
2018-Q42019-03-25n/a-0.19n/a
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a

Annual financial results

Compared to 2017, last anual revenues report draw a hair-raising drop down of -41.10% to $0.56 million dollars. When comparing 2018 vs 2017, similarly, profit margin (that is, the net income divided by revenues) plunged a -653.94% to -1,649.28%.

YTEN annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$5.39 M-$-30.51 M-566.0%-
2014$2.80 M-48.05%$-29.53 M-1054.8%-3.20%
2015$2.59 M-7.36%$-23.68 M-912.9%-19.82%
2016$1.16 M-55.32%$-7.60 M-656.1%-67.89%
2017$0.94 M-18.55%$-9.40 M-995.3%23.57%
2018$0.56 M-41.10%$-9.17 M-1649.3%-2.41%

Quarterly financial results

Yield10 Bioscience posted $0.14 million in revenues for 2018-Q4, a 77.63% up compared to previous quarter. Reported quarter income marked $-1.86 million with a profit margin of -1,377.78%. Profit margin rocketed a 2,082.75% compared to previous quarter when profit margin was -3,460.53%. When comparing sales to same quarter last year, Yield10 Bioscience sales marked an astounding gain and rocketed a 29.81%.
YTEN quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q1$0.32 M-$-2.09 M-645.1%-
2017-Q2$0.29 M-9.57%$-2.73 M-931.7%30.62%
2017-Q3$0.22 M-23.89%$-2.03 M-908.1%-25.82%
2017-Q4$0.10 M-53.36%$-2.55 M-2453.8%26.02%
2018-Q1$0.06 M-42.31%$-2.29 M-3816.7%-10.27%
2018-Q2$0.29 M375.00%$-2.39 M-838.6%4.37%
2018-Q3$0.08 M-73.33%$-2.63 M-3460.5%10.04%
2018-Q4$0.14 M77.63%$-1.86 M-1377.8%-29.28%

Yield10 Bioscience ownership

When you are planning to buy a stock, it's always worth to review its ownership structure.

Yield10 Bioscience shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 6.79% of all shares.

In case of Yield10 Bioscience stock, 19.05% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for YTEN stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Yield10 Bioscience:

YTEN
Market cap$195.0 M
Total shares28.8 M
Float shares9.5 M
  - Institutional holdings (%)19.1%
  - Insider holdings (%)6.8%
Shares in short selling0.0%

YTEN summary

Friday, January 24th, 2020
Open$6.27
Close$6.77
Day range$5.64 - $6.82
Previous close$6.25
Session gain8.32%
Average true range$1.72
50d mov avg$6.89
100d mov avg$15.83
200d mov avg$28.42
Daily pattern
Weekly pattern lt03a

Yield10 Bioscience performance

Performance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. We compared Yield10 Bioscience against in the following table:
Stock3m6m12m
YTENYield10 Bioscienc...-69.78%-80.55%-85.53%

Yield10 Bioscience competitors

Unfortunately, we could not find any public company that could be defined as Yield10 Bioscience competitor. This doesn't mean Yield10 Bioscience does not have any competitor in the market, it's just we could not detected it.